Medipal Holdings Overview
- Year Founded
-
1898
- Status
-
Public
- Employees
-
24,096
- Stock Symbol
-
7459
- Investments
-
32
- Share Price
-
$20.19
- (As of Friday Closing)
Medipal Holdings General Information
Description
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
Contact Information
Website
www.medipal.co.jpCorporate Office
- 3-1-1 Kyobashi
- Chuo-ku
- Tokyo, 104-8461
- Japan
Corporate Office
- 3-1-1 Kyobashi
- Chuo-ku
- Tokyo, 104-8461
- Japan
Medipal Holdings Stock Performance
As of 13-Nov-2026, Medipal Holdings’s stock price is $20.19. Its current market cap is $4.13B with 205M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $20.19 | $20.02 | $15.73 - $22.78 | $4.13B | 205M | 514K | $1.35 |
Medipal Holdings Financials Summary
As of 30-Sep-2026, Medipal Holdings has a trailing 12-month revenue of $24.7B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,905,415 | 2,929,171 | 2,498,477 | 2,651,540 |
| Revenue | 24,712,912 | 25,326,628 | 24,074,579 | 24,629,635 |
| EBITDA | 623,381 | 657,237 | 615,135 | 634,308 |
| Net Income | 276,210 | 282,196 | 264,128 | 287,037 |
| Total Assets | 12,527,874 | 12,023,183 | 12,195,638 | 11,887,196 |
| Total Debt | 917,315 | 0 | 0 | 0 |
Medipal Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Medipal Holdings Comparisons
Industry
Financing
Details
Medipal Holdings Competitors (5)
One of Medipal Holdings’s 5 competitors is Suzuken, a Corporation company based in Nagoya, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Suzuken | Corporation | Nagoya, Japan | ||||
| ONO Pharmaceutical | Corporation | Osaka, Japan | ||||
| Otsuka Holdings | Corporation | Tokyo, Japan | ||||
| Nipro | Corporation | Osaka, Japan | ||||
| Taisho Pharmaceutical Indonesia | Corporation | Jakarta, Indonesia |
Medipal Holdings Patents
Medipal Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026095904-A | Information processing device, information processing method, and program | Pending | 02-Dec-2024 | ||
| JP-2026029063-A | Container instrument for freezing target object | Active | 08-Aug-2024 | ||
| WO-2026034089-A1 | Frozen object accommodation device | Pending | 08-Aug-2024 | ||
| JP-7781986-B1 | Storage device for frozen objects | Active | 08-Aug-2024 | ||
| JP-2025111998-A | Information processing system and information processing method | Pending | 18-Jan-2024 |
Medipal Holdings Signals
Medipal Holdings Investments & Acquisitions (32)
Medipal Holdings’s most recent deal was a Early Stage VC with Mutex for . The deal was made on 30-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mutex | 30-Sep-2026 | Early Stage VC | Business/Productivity Software | ||
| Metagen Therapeutics | 04-Sep-2026 | Later Stage VC | Drug Discovery | ||
| MC Healthcare Group | 07-Aug-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Paltac | 08-Jul-2026 | Secondary Transaction - Private | Distributors/Wholesale | ||
| Holoeyes | 03-Jun-2025 | Later Stage VC | Medical Records Systems |
Medipal Holdings ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Medipal Holdings Exits (7)
Medipal Holdings’s most recent exit was on 03-Jun-2025 from Holoeyes. The exit was categorized as with 12 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Holoeyes | 03-Jun-2025 | Completed |
|
||
| Aculys | 11-Feb-2025 | Completed |
|
||
| Chordia Therapeutics | 13-May-2022 | Completed |
|
||
| Heartseed | 11-Jun-2021 | Completed |
|
||
| Heartseed | 10-Mar-2020 | Later Stage VC | Completed |
Medipal Holdings Affiliates
Subsidiaries (15)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Medipal Innovation | Tokyo, Japan | 2021 | |
| Falfield | Koto City, Japan | 2020 | |
| Qol Company | Tokyo, Japan | 2017 | |
| Presus Cube | Tokyo, Japan | 2016 | |
| Doctorbook | Tokyo, Japan | 2013 |
Medipal Holdings FAQs
-
When was Medipal Holdings founded?
Medipal Holdings was founded in 1898.
-
Where is Medipal Holdings headquartered?
Medipal Holdings is headquartered in Tokyo, Japan.
-
What is the size of Medipal Holdings?
Medipal Holdings has 24,096 total employees.
-
What industry is Medipal Holdings in?
Medipal Holdings’s primary industry is Drug Delivery.
-
Is Medipal Holdings a private or public company?
Medipal Holdings is a Public company.
-
What is Medipal Holdings’s stock symbol?
The ticker symbol for Medipal Holdings is 7459.
-
What is the current stock price of Medipal Holdings?
As of 13-Nov-2026 the stock price of Medipal Holdings is $20.19.
-
What is the current market cap of Medipal Holdings?
The current market capitalization of Medipal Holdings is $4.13B.
-
What is Medipal Holdings’s current revenue?
The trailing twelve month revenue for Medipal Holdings is $24.7B.
-
Who are Medipal Holdings’s competitors?
Suzuken, ONO Pharmaceutical, Otsuka Holdings, Nipro, and Taisho Pharmaceutical Indonesia are competitors of Medipal Holdings.
-
What is Medipal Holdings’s annual earnings per share (EPS)?
Medipal Holdings’s EPS for 12 months was $1.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process